# Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease

> **NCT00862446** · PHASE4 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 48 (actual)

## Conditions studied

- Parenteral Nutrition Associated Liver Disease

## Interventions

- **DRUG:** Omegaven

## Key facts

- **NCT ID:** NCT00862446
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2019-10
- **Final completion:** 2019-10
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00862446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00862446, "Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00862446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*